Abstract
Export of medicines is one of the most profitable businesses, which attracts the attention of an increasing number of producers. The international medicines’ trade largely depends on national or regional regulatory mechanisms. In addition, the export terms and conditions differ for various categories of medicines. Innovative drugs account for the main share of the global medicines’ export. Therefore, export of innovative drugs developed in Russia to advanced countries is the most economically profitable direction. Export of generic drugs can bring considerable revenue to the producer and the state, but import substitution by releasing generic drugs weakens the innovative direction of studies and production. The import substitution policy targets manufacturers of medicines to produce generic drugs, as well as products intended, mainly or exclusively, for sale within the country. One of the ways to improve the efficiency of the entire pharmaceutical sector is international cooperation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Engineering & Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
